Leave it to Wall Street to find a possible gain in someone else's pain. While PepsiCo grapples with far-flung reports of needles and syringes being found in Pepsi cans, analysts see a buy. "Ultimately, it could be a hoax. But it's an easy way to make money in the short term on the stock," says Roy Burry, beverage analyst at Kidder Peabody. Since June 14, the stock has dropped $1, closing at 35 5/8 on June 16. For its part, the company says that it's "virtually impossible for any tampering to have occurred at our bottling plants."
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.